Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 666, Issue 1-2, 2009, Pages 44-49

  Ponsa, Immaculada ^a,b,c   Ramos Quiroga, Josep Antoni ^c,d   Ribasés, Marta ^d   Bosch, Rosa ^d   Bielsa, Anna ^d   Ordeig, Maria Teresa ⁱ   Morell, Marta ^a   Miró, Rosa ^b,c   de Cid, Rafael ^a,e,f   Estivill, Xavier ^a,e,f   Casas, Miquel ^c,d   Bayés, Mònica ^a,e,f   Cormand, Bru ^g,h   Hervás, Amaia ⁱ  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b Fisiologia i Immunologia   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^f Centro Nacional de Genotipado CeGen   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

ⁱ HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

ADHD; Adult; Children; Cytogenetic effects; Methylphenidate

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; CYTOKINESIS; DRUG RELEASE; FEMALE; HUMAN; MALE; MICRONUCLEUS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SISTER CHROMATID EXCHANGE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MICRONUCLEUS TESTS; MIDDLE AGED; SISTER CHROMATID EXCHANGE;

EID: 65749090418     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2009.03.014     Document Type: Article

References (49)

1. El-Zein R.A., Abdel-Rahman S.Z., Hay M.J., Lopez M.S., Bondy M.L., Morris D.L., and Legator M.S. Cytogenetic effects in children treated with methylphenidate. Cancer Lett. 230 (2005) 284-291
2. American Academy of Pediatrics. Subcommittee on Attention-Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder, Pediatrics 108 (2001) 1033-1044.
3. Faraone S.V., Sergeant J., Gillberg C., and Biederman J. The worldwide prevalence of ADHD: is it an American condition?. World Psychiatry 2 (2003) 104-113
4. Faraone S.V., and Biederman J. What is the prevalence of adult ADHD? Results of a population screen of 966 adults. J Atten Disord. 9 (2005) 384-391
5. Mortelmans K., Haworth S., Lawlor T., Speck W., Tainer B., and Zeiger E. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. Environ. Mutagen. 8 Suppl 7 (1986) 1-119
6. Teo S.K., San R.H., Wagner V.O., Gudi R., Stirling D.I., Thomas S.D., and Khetani V.D. D-Methylphenidate is non-genotoxic in in vitro and in vivo assays. Mutat. Res. 537 (2003) 67-79
7. Suter W., Martus H.J., and Elhajouji A. Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micronucleus test. Mutat. Res. 607 (2006) 153-159
8. Walker A.P., and Dumars K.W. Commonly used pediatric drugs, sister chromatid exchanges and the cell cycle. Am. J. Hum. Genet. 29 (1977) 110A
9. Galloway S.M., Armstrong M.J., Reuben C., Colman S., Brown B., Cannon C., Bloom A.D., Nakamura F., Ahmed M., Duk S., et al. Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals. Environ. Mol. Mutagen 10 Suppl 10 (1987) 1-175
10. Andreazza A.C., Frey B.N., Valvassori S.S., Zanotto C., Gomes K.M., Comim C.M., Cassini C., Stertz L., Ribeiro L.C., Quevedo J., Kapczinski F., Berk M., and Goncalves C.A. DNA damage in rats after treatment with methylphenidate. Prog. Neuropsychopharmacol. Biol Psychiatry (2007)
11. Walitza S., Werner B., Romanos M., Warnke A., Gerlach M., and Stopper H. Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder?. Environ. Health Perspect. 115 (2007) 936-940
12. Witt K.L., Shelby M.D., Itchon-Ramos N., Faircloth M., Kissling G.E., Chrisman A.K., Ravi H., Murli H., Mattison D.R., and Kollins S.H. Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry 47 (2008) 1375-1383
13. Walitza S., Kampf K., Artamonov N., Romanos M., Gnana Oli R., Wirth S., Warnke A., Gerlach M., and Stopper H. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Toxicol. Lett. 184 (2009) 38-43
14. Preston R.J., Kollins S.H., Swanson J.M., Greenhill L.L., Wigal T., Elliott G.R., and Vitiello B. Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. Cancer Lett. 230 (2005) 292-294
15. El-Zein R.A., Hay M.J., Lopez M.S., Bondy M.L., Morris D.L., Legator M.S., and Abdel-Rahman S.Z. Response to comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al. Cancer Lett. 231 (2006) 146-148
16. Bonassi S., Znaor A., Ceppi M., Lando C., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Cebulska-Wasilewska A., Fabianova E., Fucic A., Hagmar L., Joksic G., Martelli A., Migliore L., Mirkova E., Scarfi M.R., Zijno A., Norppa H., and Fenech M. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28 (2007) 625-631
17. Oestreicher N., Friedman G.D., Jiang S.F., Chan J., Quesenberry Jr. C., and Habel L.A. Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses. Pharmacoepidemiol. Drug Saf 16 (2007) 1268-1272
18. Biederman J., Wilens T.E., Spencer T.J., and Adler L.A. Diagnosis and treatment of adults with attention-deficit/hyperactivity disorder. CNS Spectr. 12 (2007) 1-15
19. Physician drug and diagnosis audit 2003, Newton Mass, Scott-Levin Associates, 2003.
20. Diagnostic and Statistical Manual of Mental Disorders DSM-IV, American Psychiatric Association, 1994.
21. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Entrevista clínica estructurada para los trastornos del eje I del DSM-IV (1999), Versión clínica, Masson, Barcelona, Spain
22. Epstein J., Johnson D., and Conners K. Conners Adult ADHD Diagnostic Interview for DSM-IV (1999), Multi-Health Systems, North Tonawanda, NY
23. Conners C.K., Erhardt D., and Sparrow E. Conners Adult ADHD Rating Scales (1999), Multi-Health Systems, North Tonawanda, NY
24. DuPaul G., Power T., Anastopoulos A., and Reid R. ADHD Rating Scales, IV: Checklists, Norms, and Clinical Interpretation (1998), Guilford Press, New York, NY
25. Ward M.F., Wender P.H., and Reimherr F.W. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am. J. Psychiatry 150 (1993) 885-890
26. Guy W. Early Clinical Drug Evaluation (ECDEU) Assessment Manual (1976), National Institute Mental Health, Rockville
27. Wechsler D. Wechsler Adult Intelligence Scale-III (1997), Psychological Corporation, San Antonio, TX
28. Conners C.K. The computerized continuous performance test. Psychopharmacol. Bull. 21 (1985) 891-892
29. Delis D.C., Kramer J.H., Kaplin E., and Ober B.A. The California Verbal Learning Test (1987), Psychological Corporation, New York
30. Wechsler D. Wechsler Memory Scale-Revised (1987), Psychological Corporation, New York
31. Reitan R.M. Validity of the Trail Making Test as an indication of organic brain damage. Perceptual Motor Skills 8 (1958) 271-276
32. Ambrosini P.J. Historical development and present status of the schedule for affective disorders and schizophrenia for school-age children (K-SADS). J.Am.Acad.child Adolesc. Psychiatry 39 (2000) 49-58
33. Conners C.K. Conners' Rating Scales Revised (1997), Multi-Health Systems, North Tonawanda, NY
34. Ramos J.L., and Cuetos F. PROLEC-SE, Evaluación de los procesos lectores en alumnos de 3er ciclo de primaria y secundaria (b) (1999), TEA ediciones, Madrid
35. Cervera M., and Toro J. Test de analisis de lectoescritura (a) (1990), TEA ediciones, Madrid
36. Ponsa I., Barquinero J.F., Miró R., Egozcue J., and Genescà A. Non-disjunction and chromosome loss in gamma-irradiated human lymphocytes: a fluorescence in situ hybridization analysis using centromere-specific probes. Radiat. Res. 155 (2001) 424-431
37. Fenech M. The in vitro micronucleus technique. Mutat. Res. 455 (2000) 81-95
38. Savage J.R. On the nature of visible chromosomal gaps and breaks. Cytogenet. Genome. Res. 104 (2004) 46-55
39. Bolognesi C., Abbondandolo A., Barale R., Casalone R., Dalpra L., De Ferrari M., Degrassi F., Forni A., Lamberti L., Lando C., Migliore L., Padovani P., Pasquini R., Puntoni R., Sbrana I., Stella M., and Bonassi S. Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol. Biomarkers Prev. 6 (1997) 249-256
40. Zhu H.J., Patrick K.S., Yuan H.J., Wang J.S., Donovan J.L., DeVane C.L., Malcolm R., Johnson J.A., Youngblood G.L., Sweet D.H., Langaee T.Y., and Markowitz J.S. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am. J. Hum. Genet. 82 (2008) 1241-1248
41. Carrano A.V., and Natarajan A.T. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques. Mutat. Res. 204 (1988) 379-406
42. Barale R., Marrazzini A., Bacci E., Di Sibio A., Tessa A., Cocchi L., Scarcelli V., Lubrano V., Vassalle C., and Landi S. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: I. Contribution of methodological factors. Environ. Mol. Mutagen 31 (1998) 218-227
43. Neri M., Ceppi M., Knudsen L.E., Merlo D.F., Barale R., Puntoni R., and Bonassi S. Baseline micronuclei frequency in children: estimates from meta- and pooled analyses. Environ. Health Perspect. 113 (2005) 1226-1229
44. Barale R., Chelotti L., Davini T., Del Ry S., Andreassi M.G., Ballardin M., Bulleri M., He J., Baldacci S., Di Pede F., Gemignani F., and Landi S. Sister chromatid exchange and micronucleus frequency in human lymphocytes of 1,650 subjects in an Italian population: II. Contribution of sex, age, and lifestyle. Environ. Mol. Mutagen. 31 (1998) 228-242
45. Zotti-Martelli L., Migliore L., Panasiuk G., and Barale R. Micronucleus frequency in Gomel (Belarus) children affected and not affected by thyroid cancer. Mutat. Res. 440 (1999) 35-43
46. Fellay-Reynier I., Orsiere T., Sari-Minodier I., Auquier P., Zattara-Cannoni H., Capodano A.M., Coze C., De Meo M., Bernard J.L., and Botta A. Evaluation of micronucleated lymphocytes, constitutional karyotypes and anti-p53 antibodies in 21 children with various malignancies. Mutat. Res. 467 (2000) 31-39
47. Shi Q., Chen J., Adler I., Zhang J., Martin R., Pan S., Zhang X., and Shan X. Increased nondisjunction of chromosome 21 with age in human peripheral lymphocytes. Mutat. Res. 452 (2000) 27-36
48. Bonassi S., Fenech M., Lando C., Lin Y.P., Ceppi M., Chang W.P., Holland N., Kirsch-Volders M., Zeiger E., Ban S., Barale R., Bigatti M.P., Bolognesi C., Jia C., Di Giorgio M., Ferguson L.R., Fucic A., Lima O.G., Hrelia P., Krishnaja A.P., Lee T.K., Migliore L., Mikhalevich L., Mirkova E., Mosesso P., Muller W.U., Odagiri Y., Scarffi M.R., Szabova E., Vorobtsova I., Vral A., and Zijno A. HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ. Mol. Mutagen. 37 (2001) 31-45
49. Merlo D.F., Ceppi M., Stagi E., Bocchini V., Sram R.J., and Rossner P. Baseline chromosome aberrations in children. Toxicol. Lett. (2007)